Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension

Indian Journal of Pharmacology

Volumn 42, Issue 3, 2010, Pages 153-156

  Akat, Pramod B ^a   Bapat, Tushar R ^a   Murthy, Mangala B ^a   Karande, Vitthal B ^a   Burute, Shreyas R ^a  

^a Government Medical College   (India)

Author keywords

Blood pressure; diastolic BP; enalapril; hypertension; systolic BP; telmisartan

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; ENALAPRIL; GLUCOSE; HEMOGLOBIN; TELMISARTAN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ESSENTIAL HYPERTENSION; FATIGUE; GLUCOSE BLOOD LEVEL; HEADACHE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; THIN LAYER CHROMATOGRAPHY; TREATMENT DURATION; URINALYSIS;

EID: 77955451421     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.66838     Document Type: Article

References (8)

1. Jackson EK. Renin and angiotensin. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilmans The Pharmacological Basis of Therapeutics. 11th ed. New York: Mc Graw Hill Medical Publishing division; 2006. p. 789-821.
2. Ball SG, White WB. Debate: Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers-a gap in evidence-based medicine. Am J Cardiol 2003;91:15G-21G.
3. Battershill AJ, Scott LJ. Telmisartan: A review of its use in the management of hypertension. Drugs 2006;66:51-83.
4. Amerena J, Pappas S, Ouellet JP, Williams L, O'Shaughnessy D. ABPM comparison of the antihypertensive profiles of telmisartan and enalapril in patients with mild to moderate essential hypertension. Int Med Res 2002;30:543-552
5. Chen JH, Cheng JJ, Chen CY, Chiou HC, Huang TY, Tsai CD, et al. Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: A multicentre, double-blind study in Taiwanese patients. Int J Clin Pract Suppl 2004;145:29-34.
6. Alcocer L, Fernandez-Bonetti P, Campos E, Dominguez-Henkel R, de la Fuente JJ, Segovia-Ayala C. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: Results of a multicentre study. Int J Clin Pract Suppl 2004;145:23-28
7. Smith DH. Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension. Drugs 2008;68:1207-1225
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572